Tropomyosin (Tpm) is one of the main regulatory proteins in the myocardium. In some heart pathologies, interchain disulfide crosslinking in the Tpm molecule occurs. In the ventricle, this change in the structural properties of the Tpm molecule affects calcium regulation of the actin-myosin interaction. Using an in vitro motility assay, we found that Tpm crosslinking does not affect the actin-myosin interaction in the atria. We assume that the intramolecular crosslinking of Tpm in the atrium does not play such a crucial role in the pathogenesis of heart failure as it plays in the heart ventricles.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10517-019-04462-8 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!